Investigation of the cytotoxic, anti-proliferative and anti-angiogenic effects of Toluhydroquinone on Caco-2 cell line
Open Access
- 31 August 2022
- journal article
- research article
- Published by CMB Association in Cellular and Molecular Biology
- Vol. 68 (8) , 8-12
Abstract
Colorectal cancer is one of the most common types of cancer in the world. The treatment options for colorectal carcinoma generally consist of surgery, radiotherapy and chemotherapy. The drug resistance to chemotherapy agents used in the current cancer treatment has brought about the finding of new drug molecules from some plant and aquatic species in the treatment approaches. Some species of aquatic biota create novel biomolecules as potential drugs for cancer and other diseases. Toluhydroquinone belongs to these groups of biomolecules and it shows anti-oxidative, anti-inflammatory and anti-angiogenic properties. In this study, we tested the cytotoxic and anti-angiogenic effects of Toluhydroquinone on Caco-2(Human colorectal carcinoma cell line) cells. It was observed that the amount of closure of the wound space, colony forming ability (in vitro cell survivability) and formation of tubule-like structures in matrigel decreased in comparison to the control group. As a result of this study, Toluhydroquinone has cytotoxic, anti-proliferative and anti-angiogenic properties on the Caco-2 cell line.Keywords
This publication has 16 references indexed in Scilit:
- A clinically relevant heterozygous ATR mutation sensitizes colorectal cancer cells to replication stressScientific Reports, 2022
- Brown marine algae Gongolaria baccata extract protects Caco-2 cells from oxidative stress induced by tert-butyl hydroperoxideFood and Chemical Toxicology, 2021
- Preparation, characterization, and anti-colon cancer activity of oridonin-loaded long-circulating liposomesPharmaceutical Development and Technology, 2021
- Combined effects of okadaic acid and pectenotoxin-2, 13-desmethylspirolide C or yessotoxin in human intestinal Caco-2 cellsChemosphere, 2019
- In Vitro Tumorigenic Assay: Colony Forming Assay for Cancer Stem Cells2017
- Toluhydroquinone from A spergillus sp. suppress inflammatory mediators via nuclear factor-κB and mitogen-activated protein kinases pathways in lipopolysaccharide-induced RAW264.7 cellsJournal of Pharmacy and Pharmacology, 2015
- Toluhydroquinone, the secondary metabolite of marine algae symbiotic microorganism, inhibits angiogenesis in HUVECsBiomedicine & Pharmacotherapy, 2015
- Clonogenic assay of cells in vitroNature Protocols, 2006
- Marine pharmacology in 2001–2: antitumour and cytotoxic compoundsEuropean Journal of Cancer, 2004
- Colorectal Carcinoma: Diagnostic, Prognostic, and Molecular FeaturesLaboratory Investigation, 2003